This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Buchanan, A. M.
Right arrow Articles by Cunningham, C. K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buchanan, A. M.
Right arrow Articles by Cunningham, C. K.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, July 2009, p. 493-507, Vol. 22, No. 3
0893-8512/09/$08.00+0     doi:10.1128/CMR.00054-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Advances and Failures in Preventing Perinatal Human Immunodeficiency Virus Infection

Ann M. Buchanan* and Coleen K. Cunningham Author Bios

Division of Pediatric Infectious Diseases, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina

Summary: An estimated 2.5 million children are currently living with HIV, the vast majority as a result of mother-to-child transmission. Prevention of perinatal HIV infection has been immensely successful in developed countries. A comprehensive package of services, including maternal and infant antiretroviral therapy, elective cesarean section, and avoidance of breast-feeding, has resulted in transmission rates of less than 2%. However, in developing countries, access to such services is often not available, as demonstrated by the fact that the vast majority of children with HIV live in Africa. Over the past few years, many developing nations have made great strides in improving access to much-needed services. Notably, in eastern and southern Africa, the regions most affected by HIV, mother-to-child-transmission coverage rates for HIV-positive women increased from 11% in 2004 to 31% in 2006. These successes are deserving of recognition, while not losing sight of the fact that much remains to be done; currently, an estimated 75% of pregnant women worldwide have an unmet need for antiretroviral therapy. Further work is needed to determine the optimal strategy for reducing perinatal transmission among women in resource-poor settings, with a particular need for reduction of transmission via breast-feeding.

* Corresponding author. Mailing address: Division of Pediatric Infectious Diseases, Duke University Medical Center, Box T3499, Durham, NC 27710. Phone: (919) 668-4848. Fax: (919) 668-4859. E-mail: ann.buchanan{at}duke.edu

Clinical Microbiology Reviews, July 2009, p. 493-507, Vol. 22, No. 3
0893-8512/09/$08.00+0     doi:10.1128/CMR.00054-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»